Skip to main content

and
  1. No Access

    Article

    Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases

    Danaparoid is a safe and effective drug for the treatment of heparin-induced thrombocytopenia (HIT). We describe an uncommon complication: danaparoid cross-reactivity with HIT antibodies.

    B. Tardy-Poncet, M. Wolf, D. Lasne, A. Bauters, P. Ffrench in Intensive Care Medicine (2009)

  2. No Access

    Article

    Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia

    The tumor suppressor gene p16ink4a is homozygously deleted in numerous T as well as in some B lineage acute lymphoblastic leukemia (ALL). We therefore analyzed the clinical and biological implications of this fea...

    Y Mekki, R Catallo, Y Bertrand, AM Manel, P Ffrench, N Baghdassarian, P Duhaut in Leukemia (1999)

  3. No Access

    Chapter and Conference Paper

    Antifibrinolytic Therapy in Cardiac Surgery

    Both clot lysis and platelet dysfunction contribute to bleeding after cardiopulmonary bypass (CPB). Aprotinin (APT), an antifibrinolytic agent derived from bovine lung, and tranexamic acid (TA) and epsilon-ami...

    J. J. Lehot, P. Ffrench, J. F. Obadia in Anaesthesia, Pain, Intensive Care and Emer… (1997)